MedPath

Dose Reduction in Thoracic CT

Phase 1
Completed
Conditions
Lymphoma
Registration Number
NCT00188461
Lead Sponsor
University Health Network, Toronto
Brief Summary

Hypothesis: Does a 50% reduction in radiation in dose significantly affect the diagnostic quality of chest CT

Detailed Description

Patients with Lymphoma are recruited and have a follow up CT performed at 50% of the standard exposure parameters. The studies are compared for image quality with a recent (\<3 months) thoracic CT performed at standard exposure parameters.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients with Lymphoma
Read More
Exclusion Criteria
  • No recent (<3 months) thoracic CT
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Evaluating the diagnostic quality of thoracic CT exams performed at 50% of standard dose parameters
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath